IVX.DE
InVision Aktiengesellschaft [IVX.DE] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
IVX.DE Stock Summary
In the News
IVX.DE Financial details
Company Rating
Sell
Market Cap
13.41M
Income
-3M
Revenue
15.46M
Book val./share
2.75
Cash/share
3.18
Dividend
-
Dividend %
-
Employees
141
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
-4.56
Forward P/E
-
PEG
-0.55
P/S
0.9
P/B
2.22
P/C
1.89
P/FCF
-11.23
Quick Ratio
1.87
Current Ratio
2.42
Debt / Equity
1.5
LT Debt / Equity
1.46
-
-
EPS (TTM)
-1.34
EPS next Y
-
EPS next Q
-
EPS this Y
143.84%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
81.93%
Revenue last 5Y
2.05%
Revenue Q/Q
-1.43%
EPS Q/Q
27.27%
-
-
-
-
SMA20
16.67%
SMA50
16.67%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-16%
ROE
-43%
ROC
-0.14%
Gross Margin
15%
Oper. Margin
-14%
Profit Margin
-19%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
5.5-10.5
52W High
-40%
52W Low
+20%
RSI
49
Rel Volume
0.22
Avg Volume
3.04K
Volume
673
Perf Week
-0.83%
Perf Month
-8.4%
Perf Quarter
-
Perf Half Y
-13.04%
-
-
-
-
Beta
0.726
-
-
Volatility
1.3%, 0.7%
Prev Close
0%
Price
6
Change
0%
IVX.DE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 5.85 | 5.65 | 5.71 | 6.13 | 6.47 | |
| Net income per share | -0.09 | 1.32 | 0.13 | -0.73 | -1.78 | |
| Operating cash flow per share | 0 | 0.67 | 0.43 | -0.26 | -1.06 | |
| Free cash flow per share | -0.16 | 0.6 | 0.39 | -0.37 | -1.1 | |
| Cash per share | 0.3 | 1.17 | 3.49 | 2.84 | 2.9 | |
| Book value per share | 4.55 | 5.87 | 6 | 5.31 | 3.56 | |
| Tangible book value per share | 4.41 | 5.74 | 5.89 | 5.19 | 3.46 | |
| Share holders equity per share | 4.55 | 5.87 | 6 | 5.31 | 3.56 | |
| Interest debt per share | 0.12 | 1.22 | 3.19 | 2.88 | 4.17 | |
| Market cap | 39.78M | 45.59M | 46.04M | 55.43M | 23.24M | |
| Enterprise value | 39.36M | 45.6M | 45.27M | 55.42M | 25.94M | |
| P/E ratio | -199.3 | 15.48 | 160.02 | -33.92 | -5.84 | |
| Price to sales ratio | 3.04 | 3.61 | 3.61 | 4.05 | 1.61 | |
| POCF ratio | 3.79K | 30.59 | 48.35 | -96.13 | -9.77 | |
| PFCF ratio | -114.55 | 34.14 | 52.78 | -67.8 | -9.43 | |
| P/B Ratio | 3.91 | 3.47 | 3.43 | 4.67 | 2.92 | |
| PTB ratio | 3.91 | 3.47 | 3.43 | 4.67 | 2.92 | |
| EV to sales | 3.01 | 3.61 | 3.55 | 4.05 | 1.79 | |
| Enterprise value over EBITDA | 46.41 | 26.03 | 25.65 | -2.88K | -10.9 | |
| EV to operating cash flow | 3.75K | 30.6 | 47.53 | -96.12 | -10.9 | |
| EV to free cash flow | -113.34 | 34.15 | 51.89 | -67.79 | -10.53 | |
| Earnings yield | -0.01 | 0.06 | 0.01 | -0.03 | -0.17 | |
| Free cash flow yield | -0.01 | 0.03 | 0.02 | -0.01 | -0.11 | |
| Debt to equity | 0.02 | 0.2 | 0.52 | 0.53 | 1.15 | |
| Debt to assets | 0.02 | 0.14 | 0.31 | 0.32 | 0.49 | |
| Net debt to EBITDA | -0.5 | 0.01 | -0.44 | 0.29 | -1.13 | |
| Current ratio | 1.27 | 1.27 | 3.02 | 4.12 | 4.23 | |
| Interest coverage | 19.38 | 9.08 | 10.61 | -7.72 | -23.29 | |
| Income quality | -0.04 | 0.5 | 2.56 | 0.35 | 0.6 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.03 | 0.04 | 0.05 | 0.06 | 0.07 | |
| Research and developement to revenue | 0 | 0.45 | 0.41 | 0.4 | 0.5 | |
| Intangibles to total assets | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | |
| Capex to operating cash flow | -34.08 | -0.1 | -0.08 | 0.42 | 0.04 | |
| Capex to revenue | -0.03 | -0.01 | -0.01 | -0.02 | -0.01 | |
| Capex to depreciation | -0.61 | -0.21 | -0.12 | -0.34 | -0.12 | |
| Stock based compensation to revenue | 0 | 0.27 | -0.05 | 0 | 0.01 | |
| Graham number | 3.03 | 13.2 | 4.17 | 9.35 | 11.95 | |
| ROIC | -0.02 | 0.19 | 0.02 | -0.07 | -0.21 | |
| Return on tangible assets | -0.02 | 0.16 | 0.01 | -0.08 | -0.21 | |
| Graham Net | -0.55 | -0.7 | -0.08 | -0.22 | -1.41 | |
| Working capital | 512.38K | 835.16K | 6.28M | 6.16M | 6.35M | |
| Tangible asset value | 9.85M | 12.83M | 13.17M | 11.6M | 7.73M | |
| Net current asset value | 512.38K | -1.13M | 407.51K | 14.35K | -2.63M | |
| Invested capital | 0.02 | 0.2 | 0.52 | 0.53 | 1.15 | |
| Average receivables | 0 | 601.32K | 1.28M | 1.47M | 1.6M | |
| Average payables | 219.25K | 215.18K | 127.92K | 122.75K | 162.06K | |
| Average inventory | 0 | 0.5 | 1 | 90.5K | 192K | |
| Days sales outstanding | 0 | 34.79 | 38.98 | 42.33 | 40.54 | |
| Days payables outstanding | 550.66 | 19.87K | 70.15K | 18.59K | 4.82 | |
| Days of inventory on hand | 0 | 0.12 | 0.75 | 22.21K | 5.67 | |
| Receivables turnover | 0 | 10.49 | 9.36 | 8.62 | 9 | |
| Payables turnover | 0.66 | 0.02 | 0.01 | 0.02 | 75.76 | |
| Inventory turnover | 0 | 2.97K | 489 | 0.02 | 64.42 | |
| ROE | -0.02 | 0.22 | 0.02 | -0.14 | -0.5 | |
| Capex per share | -0.16 | -0.07 | -0.04 | -0.11 | -0.04 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.03 | 1.67 | 1.68 | 1.8 | 1.77 | |
| Net income per share | -0.01 | -0.45 | -0.39 | -0.22 | -0.28 | |
| Operating cash flow per share | -0.01 | -0.89 | 0.79 | 0.02 | -0.46 | |
| Free cash flow per share | -0.01 | -0.9 | 0.79 | 0.02 | -0.46 | |
| Cash per share | 0.08 | 2.9 | 3.65 | 3.66 | 3.18 | |
| Book value per share | 0.08 | 3.56 | 3.2 | 2.99 | 2.75 | |
| Tangible book value per share | 0.08 | 3.46 | 3.1 | 2.9 | 2.75 | |
| Share holders equity per share | 0.08 | 3.56 | 3.2 | 2.99 | 2.75 | |
| Interest debt per share | 0.09 | 4.15 | 4.18 | 4.15 | 4.12 | |
| Market cap | 1.38B | 23.24M | 21.23M | 15.53M | 16.54M | |
| Enterprise value | 1.38B | 25.94M | 22.37M | 16.59M | 18.63M | |
| P/E ratio | -332.55 | -5.79 | -6.11 | -7.89 | -6.55 | |
| Price to sales ratio | 379.22 | 6.22 | 5.66 | 3.87 | 4.18 | |
| POCF ratio | -893.79 | -11.66 | 11.98 | 285.68 | -16.02 | |
| PFCF ratio | -891.34 | -11.6 | 12.04 | 366 | -15.95 | |
| P/B Ratio | 153.25 | 2.92 | 2.97 | 2.32 | 2.69 | |
| PTB ratio | 153.25 | 2.92 | 2.97 | 2.32 | 2.69 | |
| EV to sales | 379.36 | 6.94 | 5.97 | 4.13 | 4.71 | |
| Enterprise value over EBITDA | -2.19K | -44.32 | -48.97 | -84.6 | -101.99 | |
| EV to operating cash flow | -894.13 | -13.01 | 12.62 | 305.17 | -18.05 | |
| EV to free cash flow | -891.68 | -12.95 | 12.68 | 390.97 | -17.97 | |
| Earnings yield | 0 | -0.04 | -0.04 | -0.03 | -0.04 | |
| Free cash flow yield | 0 | -0.09 | 0.08 | 0 | -0.06 | |
| Debt to equity | 1.03 | 1.15 | 1.3 | 1.38 | 1.5 | |
| Debt to assets | 0.44 | 0.49 | 0.43 | 0.46 | 0.49 | |
| Net debt to EBITDA | -0.83 | -4.61 | -2.49 | -5.4 | -11.46 | |
| Current ratio | 3.23 | 4.23 | 2.05 | 2.25 | 2.42 | |
| Interest coverage | 19.39 | -9.55 | -14.14 | -23.07 | 0 | |
| Income quality | 1.49 | 1.99 | -2.04 | -0.1 | 1.85 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 1.14 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 1.94 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Capex to operating cash flow | 0 | 0.01 | 0 | -0.22 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | -0.02 | -0.06 | -0.04 | -0.07 | -0.03 | |
| Stock based compensation to revenue | -0.05 | 0.04 | -0.05 | -0.04 | -0.04 | |
| Graham number | 0.13 | 6 | 5.29 | 3.85 | 4.18 | |
| ROIC | -0.05 | -0.05 | -0.05 | -0.03 | -0.03 | |
| Return on tangible assets | -0.05 | -0.05 | -0.04 | -0.02 | -0.03 | |
| Graham Net | -0.02 | -1.41 | -1.92 | -1.84 | -1.96 | |
| Working capital | 7.07M | 6.35M | 5.81M | 5.65M | 5.4M | |
| Tangible asset value | 8.73M | 7.73M | 6.93M | 6.48M | 5.96M | |
| Net current asset value | -1.97M | -2.63M | -3.27M | -3.39M | -3.58M | |
| Invested capital | 1.03 | 1.15 | 1.3 | 1.38 | 1.5 | |
| Average receivables | 1.41M | 1.44M | 2.24M | 2.26M | 1.68M | |
| Average payables | 265.66K | 224.6K | 211.48K | 263.36K | 290.07K | |
| Average inventory | 0.5 | 101.5K | 101.5K | 1 | 0.5 | |
| Days sales outstanding | 31.58 | 38.66 | 68.74 | 37.19 | 38.87 | |
| Days payables outstanding | 7.43 | 4.57 | 6.81 | 7.65 | 8.51 | |
| Days of inventory on hand | 0 | 5.37 | 0 | 0 | 0 | |
| Receivables turnover | 2.85 | 2.33 | 1.31 | 2.42 | 2.32 | |
| Payables turnover | 12.12 | 19.71 | 13.21 | 11.77 | 10.57 | |
| Inventory turnover | 0 | 16.76 | 3.31M | 3.25M | 0 | |
| ROE | -0.12 | -0.13 | -0.12 | -0.07 | -0.1 | |
| Capex per share | 0 | 0 | 0 | -0.01 | 0 |
IVX.DE Frequently Asked Questions
What is InVision Aktiengesellschaft stock symbol ?
InVision Aktiengesellschaft is a DE stock and trading under the symbol IVX.DE
What is InVision Aktiengesellschaft stock quote today ?
InVision Aktiengesellschaft stock price is $6 today.
Is InVision Aktiengesellschaft stock public?
Yes, InVision Aktiengesellschaft is a publicly traded company.
Company Profile
- Volume Average 3.04K
- Market Capitalization 13.41M
- Employee 141
- CEO Mr. Peter Bollenbeck
- Headquarters Düsseldorf,DE
- IPO Date 2007-06-18
-
Website
https://www.ivx.com 
InVision Aktiengesellschaft, together with its subsidiaries, develops and markets products and services in the field of workforce management and education in Europe and the United States. The company offers products, such as injixo, a cloud-based workforce management software to optimize workforce planning process; and The Call Center School, a cloud-based e-learning solution. InVision Aktiengesellschaft was founded in 1995 and is headquartered in Düsseldorf, Germany.
